AtriCure Medical (ATRC): יחס שווי שוק להכנסות החברה

AtriCure, Inc. (ATRC) is a recognized leader in the development of atrial fibrillation therapy tools, enjoying global trust from physicians. Stable demand for cardiac surgeries ensures business resilience, as evidenced by the company's average P/S ratio, which settled at 4.80. A narrow operational profile guarantees high margins and efficient production scaling with low costs.

For AtriCure, Inc. (ATRC), which drives innovation in arrhythmia treatment through partnerships with cardiac surgeons, this indicator reflects the market value of the business relative to generated sales volume. By analyzing the P/S ratio chart, an investor assesses the relationship between market capitalization and revenue, allowing them to promptly identify unjustified price growth amid stagnating income and avoid the risks of a deep asset correction.